Nor)Clozapine Kinetics and Side Effects in Therapy Resistant Schizophrenia and the Optimal Sampling Time for Therapeutic Drug Monitoring

Clinical trial NCT06749041 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06749041
Sponsor: GGZ Noord-Holland-Noord
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Cardiovascular Side Effects of Clozapine Neutropenia Due to Clozapine General Side Effects of Clozapine Constipation Due to Clozapine Symptoms of Schizophrenia Optimal Blood Sampling Time for Clozapine in Patients Who Receive Clozapine Once and Twice Daily Clozapine and Norclozapine Plasma Level Concentrations

Start date: 2024-12-23
Primary completion: 2027-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.